Unconventional Approaches Pharma Is Taking to Engage Patients
PM360
SEPTEMBER 7, 2023
Mason learned that lesson while working with argenx to launch VYVGART (efgartigimod alfa-fcab), the first FDA-approved treatment of its kind for adults with anti-AChR antibody positive generalized myasthenia gravis (gMG), a rare autoimmune neuromuscular disease. We also put big pull tags on the little pouches that held the items.
105 
Let's personalize your content